Showing 1 - 10 of 12
Persistent link: https://www.econbiz.de/10010946921
Persistent link: https://www.econbiz.de/10010947326
Persistent link: https://www.econbiz.de/10010948095
Persistent link: https://www.econbiz.de/10010948428
Persistent link: https://www.econbiz.de/10011036199
A controversial topic in obstetrics is the effect of walking on the probability of Caesarean section among women in labour. A major reason for the controversy is the presence of non-compliance that complicates the estimation of efficacy, the effect of treatment received on outcome. The...
Persistent link: https://www.econbiz.de/10005691986
Persistent link: https://www.econbiz.de/10005732406
Because many medical decisions are based on risk prediction models that are constructed from medical history and results of tests, the evaluation of these prediction models is important. This paper makes five contributions to this evaluation: the relative utility curve which gauges the potential...
Persistent link: https://www.econbiz.de/10008537017
When evaluating potential interventions for cancer prevention, it is necessary to compare benefits and harms. With new study designs, new statistical approaches may be needed to facilitate this comparison. A case in point arose in a proposed genetic substudy of a randomized trial of tamoxifen...
Persistent link: https://www.econbiz.de/10005309445
We define a surrogate end point as a measure or indicator of a biological process that is obtained sooner, at less cost or less invasively than a true end point of health outcome and is used to make conclusions about the effect of an intervention on the true end point. Prentice presented...
Persistent link: https://www.econbiz.de/10005276876